When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Angle-closure glaucoma

Last reviewed: 23 Jun 2024
Last updated: 10 Nov 2023

Summary

Definition

History and exam

Key diagnostic factors

  • halos around lights
  • aching eye or brow pain
  • headache
  • nausea, vomiting
  • reduced visual acuity
  • eye redness
  • elevated intraocular pressure (IOP)
  • corneal edema
  • fixed dilated pupil
Full details

Other diagnostic factors

  • use of medications that induce angle narrowing
  • incidental eye findings
  • blurred vision
  • corneal hysteresis
  • change in vision
Full details

Risk factors

  • female sex
  • hyperopia
  • shallow peripheral anterior chamber
  • second eye having angle closure
  • Inuit and Asian ethnicity
  • advanced age
  • family history
  • use of medications that induce angle narrowing
  • corneal hysteresis
Full details

Diagnostic tests

1st tests to order

  • gonioscopy, examination of anterior chamber angle
  • slit lamp examination
  • automatic static perimetry
Full details

Tests to consider

  • ultrasound biomicroscopy
  • anterior segment optical coherence tomography (of angle)
  • evaluation of the optic nerve head by fundoscopy
  • retinal optical coherence tomography
  • Heidelberg retinal tomography
  • GDx nerve fiber analyzer
Full details

Emerging tests

  • corneal hysteresis

Treatment algorithm

ACUTE

initial presentation: acute angle-closure glaucoma

initial presentation: chronic angle-closure glaucoma

ONGOING

residual angle closure after laser peripheral iridotomy with elevated intraocular pressure

repeat episode of acute angle-closure glaucoma

Contributors

Authors

Brian A. Francis, MD, MS

Riffenburgh Professorship in Glaucoma

Associate Professor of Ophthalmology

Doheny Eye Institute

Department of Ophthalmology

Keck School of Medicine

University of Southern California

Los Angeles

CA

Disclosures

BAF is a consultant for Diopsys, Endo Optiks, Glaukos, NeoMedix, and Bausch Health. BAF is a speaker for Bausch + Lomb, and has given expert opinion to Valentine Law Group and Reback, McAndrews, Kjar, Warford & Stockalper, LLP.

Stephanie Midtling, MD

Glaucoma Fellow

Department of Ophthalmology

UCLA Stein Eye Institute

Doheny Eye Centers UCLA

Los Angeles

CA

Disclosures

SM declares that she has no competing interests.

Acknowledgements

Dr Brian A. Francis and Dr Stephanie Midtling would like to gratefully acknowledge Dr Ani Khondkaryan, Dr Yaniv Barkana, and Dr Noa Chetrit, previous contributors to this topic. AK, YB, and NC declare that they have no competing interests.

Peer reviewers

Gus Gazzard, MA, MBBChir, MD, FRCOphth

Consultant Ophthalmic Surgeon

King's College Hospital

Honorary Research Fellow

Institute of Ophthalmology

London

UK

Disclosures

GG declares that he has no competing interests.

Edward J. Rockwood, MD

Associate Professor of Ophthalmology

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Cole Eye Institute

Cleveland Clinic

Cleveland

OH

Disclosures

EJR has received one honorarium from Pfizer, Inc. (manufacturers of Xalatan) for a speaking engagement.

  • Differentials

    • Open-angle glaucoma (primary and secondary)
    • Other optic neuropathies (e.g., compressive)
    • Eye trauma
    More Differentials
  • Guidelines

    • Glaucoma summary benchmarks​
    • Vision rehabilitation preferred practice pattern
    More Guidelines
  • Patient information

    Glaucoma (open angle)

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer